Arana RJC, Corona BA

Idioma: Español
Referencias bibliográficas: 29
Paginas: 204-209
Archivo PDF: 59.54 Kb.

FRAGMENTO

Definición El cáncer gástrico es la neoplasia más frecuente del tubo digestivo en todo el mundo.1,2 El término cáncer gástrico se refiere a los adenocarcinomas del estómago, que representan un 95% de los tumores malignos de este órgano.3,4 Salvo en Japón, el carcinoma del estómago en general se encuentra en una fase evolutiva avanzada en el momento del diagnóstico, con infiltración más allá de la submucosa e invasión de la pared gástrica.3

REFERENCIAS (EN ESTE ARTÍCULO)

1. Tierney L y cols. Diagnóstico clínico y tratamiento 35ª Edición. Tumores malignos de estómago. Pgs. 585-86. Ed. Manual Moderno.

2. Corral VB. Cáncer gástrico. Estado actual. Cirujano General 1999; 21 (1).

3. Zinner MJ, Schwartz SI, Ellis H. Operaciones Abdominales 10ª Edición. Tumores gástricos. Pgs 927-54. Ed. Interamericana.

4. Soto AV, Cruz OH, Salas GJ, Murgía D. Cáncer gástrico: caso clínico-patológico. Rev Fac Med UNAM 2001; 44(3): 133-36.

5. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2(9): 533-43.

6. Tejer CP, Ziogas A, Kurosaki T, Butler J, Antón-Culver H. Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall an cancer specific survival rates. Cancer 2000; 89(9): 1883-92.

7. De Vita VT, Hellman S, Rosenberg SA. Cancer: Principles and practice of Oncology 6a Ed. Cancer of the stomach. Pgs. 1092-1126. Edit. Lippincott Williams and Wilkins.

8. Registro Histopatológico de Neoplasias Malignas en México. SSA. 2000.

9. Setiawan VW, Zhang ZF, Yu GP, et all. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer epidemiology, Biomarkers and prevention. 2000; 9(1): 73-80.

10. Xia HH, Kalantar JS, Talley NJ, et all. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? American Journal of Gastroenterology. 2000; 95(1): 114-21.

11. Alexander GA. Association of Helicobacter pylori infection with gastric cancer. Military Medicine 2000; 165(1): 21-27.

12. Schwartz SI, Shires GT, Fischer JF. Principios de Cirugía 7ª Edición. Oncología; Biología de la transformación maligna. Pgs 330-51. Ed. Mc Graw-Hill Interamericana SA de CV.

13. Villar HV. Tumor biology. Cirujano General 1999; 21(1): 9-14.

14. Chi Wook S, et al. Association of pseudoachalasia with advancing cancer of gastric cardia. Gastrointestinal Endoscopy 1999; 50(4).

15. Da Costa RS, Wilson BC, Marcon NE. Light induced fluorescence endoscopy of the gastrointestinal tract. Gastrointestinal endoscopy Clinics of North America 2000; 10(1): 37-69.

16. Bhunchet E, Hatakawa H, Sakai Y, ShibataT. Fluorescein electronic endoscopy: A novel method for detection of early stage gastric cancer not evident to routine endoscopy. Gastrointestinal Endoscopy 2002; 55(4).

17. Marrelli D, et al. Clinical utility of ACE, CA19-9 and CA72-4 in the follow-up of patients with resectable gastric cancer. American Journal of Surgery 2001; 181(1).

18. Martin IG, Cutts SG, Birbeck, Gray S, Quirke P. Expression of the 17-1ª antigen in gastric and gastroesophageal junction adenocarcinomas: a potential immunotherapeutic target? Journal of Clinical Pathology 1999; 52(9): 701-4.

19. Handa Y, Saitoh T, Kawaguchi M, et all. Production of secretory component and pathogenesis of gastric cancer in Helicobacter pylori-infected stomach. Journal of Gastroenterology 1999; 34 Suppl. 11: 37-42.

20. Chan YM, Nagai SW, Lao TT. Gastric adenocarcinoma presenting with persistent, mild gastrointestinal symptoms in pregnancy. A case report. Journal of Reproductive Medicine 1999; 44(11): 986-88.

21. Jaspers VK, Gillessen A, Quakernack K. Gastric cancer in pregnancy: do pregnancy, age or female sex ajter the prognosis?. Case reports and review. European Journal of Obstetrics, Gynecology and Reproductive Biology 1999; 87(1): 13-22.

22. Hartgrink HH, Bonenkamp HJ, Van de Velde CJ. Influence of surgery on outcomes in gastric cancer. Surgical Oncology Clinics of North America 2000; 9(1): 97-117.

23. Gonzáles BM, Ordóñez A, Feliu J, Zamora P, Espinoza E, De Castro J. Oncología Clínica 2ª Edición. Cáncer Gástrico. Pgs: 133-48. Ed. Interamericana.

24. A prospective Randomized Trial Comparing R1 Subtotal Gastrectomy with R3 Total gastrectomy for antral cancer. Robertson CS, Woods SDS, Raimes SA, Li AKC. Annals of Surgery. 1994; 220(2): 176-82.

25. Shimizu S, Uchiyama A, Mizumoto K, et all. Laparoscopically assisted distal gastrectomy for early gastric cancer: is superior to open surgery? Surgical Endoscopy 2000; 14(1): 27-31.

26. James LW, Harbison SP, Stiller GD, et all. Neoadjuvant chemotherapy (IORT): Improved treatment for gastric adenocarcinoma. Surgery 2000; 128(4): 564-69.

27. Gallardo RD, Oñate OLF, Calderillo RG. Neoadjuvant chemotherapy with P-ELF (Cisplatin, etoposide, leucovorin, 5-fluoruracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study. Annals of Surgical Oncology 2000; 7(1): 45-50.

28. Sainz R, Borda F, Dominguez E, Gisbert JP. Helicobacter pylori infection. The spanish consensus report. The spanish consensus conference Group. Revista Española de Enfermedades Digestivas. 1999; 91(11): 777-84.

29. Gotoda T, Saito D, Kondo H. Endoscopic and histological reversibility of gastric adenoma after erradication of Helicobacter pylori. Journal of Gastroenterology 1999; 34 Suppl. 11: 91-6.